Skip to content

Effect of the Stellate Ganglion Block on the Retinal Microcirculation

Effect of the Stellate Ganglion Block on the Retinal Microcirculation: A Pilot Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06797752
Enrollment
50
Registered
2025-01-28
Start date
2024-10-07
Completion date
2026-10-07
Last updated
2025-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracerebral Hemorrhage, OCTA, Severe Brain Injury, Subarachnoid Hemorrhage

Brief summary

Surges in the sympathetic nervous system occur at the ictus of a variety of neurological critical illnesses including intracranial hemorrhage and ischemic stroke. It is hypothesized that these exaggerated increases in sympathetic nervous activity produce maladaptations that promote secondary brain injury. One of these possible mechanisms include diffuse vasospasm that cause cerebral ischemia. Hence, methods to abrogate the sympathetic nervous system in this context are under active investigation. One possible method is the regional anesthesia technique of the stellate ganglion nerve block, which is ordinarily used for complex regional pain syndrome, but has been shown to reduce cerebral sympathetic activity and reduces vasospasm in patients with subarachnoid hemorrhage. However, its effect on the microcirculation is not clear. Hence, we propose to study patients receiving the stellate ganglion nerve block as part of their standard medical care and to image their retinal microcirculation before and after the procedure using Optical Coherence Tomography Angiography (OCTA).

Interventions

DEVICEOCTA Scan

Optical Coherence Tomography Angiography before and after receiving the stellate ganglion nerve block.

Sponsors

University of Texas Southwestern Medical Center
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 years or older * Patients receiving the stellate ganglion nerve block for an approved indication, e.g. complex regional pain syndrome

Exclusion criteria

* Pregnancy * Non-English speaking * Temporary or permanent physical limitation that renders the patient unable to sit up and look inside OCTA device

Design outcomes

Primary

MeasureTime frameDescription
Vascular and Perfusion DensityOne dayQuantitative measure of retinal microperfusion

Countries

United States

Contacts

Primary ContactNoah Jouett, DO, PhD
noah.jouett@utsouthwestern.edu214-645-7011

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026